CDTX logo

Cidara Therapeutics, Inc. (CDTX) Operating Profit

Annual Operating Profit:

-$176.10M-$149.04M(-550.78%)
December 31, 2024

Summary

  • As of today, CDTX annual operating income is -$176.10 million, with the most recent change of -$149.04 million (-550.78%) on December 31, 2024.
  • During the last 3 years, CDTX annual operating profit has fallen by -$133.85 million (-316.76%).
  • CDTX annual operating profit is now -16175.60% below its all-time high of -$1.08 million, reached on December 31, 2013.

Performance

CDTX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXincome statement metrics

Quarterly Operating Profit:

-$27.38M-$2.12M(-8.37%)
June 30, 2025

Summary

  • As of today, CDTX quarterly operating income is -$27.38 million, with the most recent change of -$2.12 million (-8.37%) on June 30, 2025.
  • Over the past year, CDTX quarterly operating profit has dropped by -$16.28 million (-146.68%).
  • CDTX quarterly operating profit is now -283.50% below its all-time high of $14.92 million, reached on September 30, 2022.

Performance

CDTX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXincome statement metrics

TTM Operating Profit:

-$124.23M-$16.28M(-15.08%)
June 30, 2025

Summary

  • As of today, CDTX TTM operating income is -$124.23 million, with the most recent change of -$16.28 million (-15.08%) on June 30, 2025.
  • Over the past year, CDTX TTM operating profit has dropped by -$91.42 million (-278.61%).
  • CDTX TTM operating profit is now -22123.43% below its all-time high of -$559.00 thousand, reached on March 31, 2014.

Performance

CDTX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

CDTX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-550.8%-146.7%-278.6%
3Y3 Years-316.8%-108.8%-87.7%
5Y5 Years-322.1%-50.4%-93.0%

CDTX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-550.8%at low-283.5%+49.5%-1937.9%at low
5Y5-Year-550.8%at low-283.5%+49.5%-1937.9%at low
All-TimeAll-Time>-9999.0%at low-283.5%+49.5%>-9999.0%at low

CDTX Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$27.38M(-8.4%)
-$124.23M(-15.1%)
Mar 2025
-
-$25.27M(+53.4%)
-$107.95M(-18.3%)
Dec 2024
-$176.10M(-550.8%)
-$54.18M(-211.5%)
-$91.22M(-99.4%)
Sep 2024
-
-$17.39M(-56.7%)
-$45.74M(-39.4%)
Jun 2024
-
-$11.10M(-30.0%)
-$32.81M(-15.3%)
Mar 2024
-
-$8.54M(+1.8%)
-$28.46M(-66.1%)
Dec 2023
-$27.06M(+19.2%)
-$8.70M(-94.7%)
-$17.14M(+32.8%)
Sep 2023
-
-$4.47M(+33.8%)
-$25.49M(-318.1%)
Jun 2023
-
-$6.75M(-342.6%)
-$6.10M(+51.1%)
Mar 2023
-
$2.78M(+116.3%)
-$12.46M(+62.8%)
Dec 2022
-$33.50M(+20.7%)
-$17.05M(-214.3%)
-$33.50M(-0.8%)
Sep 2022
-
$14.92M(+213.8%)
-$33.22M(+49.8%)
Jun 2022
-
-$13.11M(+28.2%)
-$66.18M(-56.5%)
Mar 2022
-
-$18.26M(-8.9%)
-$42.29M(-0.1%)
Dec 2021
-$42.26M(+41.2%)
-$16.77M(+7.0%)
-$42.26M(+10.2%)
Sep 2021
-
-$18.04M(-267.4%)
-$47.03M(-1.1%)
Jun 2021
-
$10.77M(+159.1%)
-$46.53M(+38.4%)
Mar 2021
-
-$18.22M(+15.4%)
-$75.51M(-5.1%)
Dec 2020
-$71.85M(-72.2%)
-$21.55M(-22.9%)
-$71.85M(-11.6%)
Sep 2020
-
-$17.53M(+3.7%)
-$64.38M(-46.9%)
Jun 2020
-
-$18.21M(-25.1%)
-$43.82M(-9.9%)
Mar 2020
-
-$14.56M(-3.4%)
-$39.88M(+4.4%)
Dec 2019
-$41.72M
-$14.08M(-565.0%)
-$41.72M(+5.7%)
DateAnnualQuarterlyTTM
Sep 2019
-
$3.03M(+121.2%)
-$44.24M(+28.6%)
Jun 2019
-
-$14.27M(+13.0%)
-$61.99M(+1.4%)
Mar 2019
-
-$16.40M(+1.2%)
-$62.88M(+0.6%)
Dec 2018
-$63.28M(-13.6%)
-$16.60M(-12.7%)
-$63.28M(-5.2%)
Sep 2018
-
-$14.72M(+2.8%)
-$60.15M(-4.3%)
Jun 2018
-
-$15.15M(+9.9%)
-$57.67M(+2.5%)
Mar 2018
-
-$16.81M(-24.9%)
-$59.13M(-6.1%)
Dec 2017
-$55.72M(-15.0%)
-$13.46M(-9.9%)
-$55.72M(+1.6%)
Sep 2017
-
-$12.25M(+26.3%)
-$56.62M(+0.2%)
Jun 2017
-
-$16.61M(-24.0%)
-$56.70M(-9.1%)
Mar 2017
-
-$13.40M(+6.7%)
-$51.95M(-7.3%)
Dec 2016
-$48.44M(-49.9%)
-$14.35M(-16.4%)
-$48.44M(-10.1%)
Sep 2016
-
-$12.34M(-4.0%)
-$44.01M(-7.7%)
Jun 2016
-
-$11.86M(-20.0%)
-$40.88M(-15.3%)
Mar 2016
-
-$9.88M(+0.4%)
-$35.47M(-9.8%)
Dec 2015
-$32.31M(-222.6%)
-$9.93M(-7.8%)
-$32.31M(-19.5%)
Sep 2015
-
-$9.21M(-42.8%)
-$27.03M(-27.8%)
Jun 2015
-
-$6.45M(+4.2%)
-$21.15M(-30.6%)
Mar 2015
-
-$6.73M(-44.8%)
-$16.19M(-61.6%)
Dec 2014
-$10.02M(-825.7%)
-$4.65M(-40.0%)
-$10.02M(-86.6%)
Sep 2014
-
-$3.32M(-123.1%)
-$5.37M(-162.2%)
Jun 2014
-
-$1.49M(-166.2%)
-$2.05M(-266.2%)
Mar 2014
-
-$559.00K
-$559.00K
Dec 2013
-$1.08M
-
-

FAQ

  • What is Cidara Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Cidara Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Cidara Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. TTM operating profit year-on-year change?

What is Cidara Therapeutics, Inc. annual operating income?

The current annual operating profit of CDTX is -$176.10M

What is the all-time high annual operating profit for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high annual operating income is -$1.08M

What is Cidara Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, CDTX annual operating income has changed by -$149.04M (-550.78%)

What is Cidara Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of CDTX is -$27.38M

What is the all-time high quarterly operating profit for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high quarterly operating income is $14.92M

What is Cidara Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, CDTX quarterly operating income has changed by -$16.28M (-146.68%)

What is Cidara Therapeutics, Inc. TTM operating income?

The current TTM operating profit of CDTX is -$124.23M

What is the all-time high TTM operating profit for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high TTM operating income is -$559.00K

What is Cidara Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, CDTX TTM operating income has changed by -$91.42M (-278.61%)
On this page